Genetic abnormalities in pancreatic cancer

Molecular Cancer

Volumn 2, Issue , 2003, Pages

  Moore, Patrick S ^a   Beghelli, Stefania ^a   Zamboni, Giuseppe ^a   Scarpa, Aldo ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FRAGILE HISTIDINE TRIAD PROTEIN; K RAS PROTEIN; PROTEIN P16; PROTEIN P53; SMAD4 PROTEIN; ACID ANHYDRIDE HYDROLASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA BINDING PROTEIN; SMAD4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ACINAR CELL CARCINOMA; CANCER DIAGNOSIS; CANCER GENETICS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CYSTADENOMA; DNA METHYLATION; EARLY DIAGNOSIS; ENDOCRINE TUMOR; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC SCREENING; HUMAN; MOLECULAR GENETICS; PANCREAS ADENOCARCINOMA; PANCREAS FUNCTION; PROGNOSIS; REVIEW; SERIAL ANALYSIS OF GENE EXPRESSION; GENETICS; MUTATION; ONCOGENE RAS; PANCREAS TUMOR; PATHOLOGY;

ACID ANHYDRIDE HYDROLASES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA-BINDING PROTEINS; GENES, RAS; HUMANS; MUTATION; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; SMAD4 PROTEIN; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2342504277     PISSN: 14764598     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-4598-2-7     Document Type: Review

References (62)

1. Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH and Yeo CJ Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 1997, 57:1731-4
2. Moore PS, Orlandini S, Zamboni G, Capelli P, Rigaud G, Falconi M, Bassi C, Lemoine NR and Scarpa A Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br J Cancer 2001, 84:253-62
3. Sorio C, Baron A, Orlandini S, Zamboni G, Pederzoli P, Huebner K and Scarpa A The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers. Cancer Res 1999, 59:1308-1314
4. Hiyama E, Kodama T, Shinbara K, Iwao T, Itoh M, Hiyama K, Shay JW, Matsuura Y and Yokoyama T Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 1997, 57:326-31
5. Villanueva A, Garcia C, Paules AB, Vicente M, Megias M, Reyes G, de Villalonga P, Agell N, Lluis F and Bachs O Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells. Oncogene 1998, 17:1969-78
6. Su GH, Hilgers W, Shekher MC, Tang DJ, Yeo CJ, Hruban RH and Kern SE Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res 1998, 58:2339-42
7. Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH and Kern SE Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res 1998, 58:5329-32
8. Su GH, Hruban RH, Bansal RK, Bova GS, Tang DJ, Shekher MC, Westerman AM, Entius MM, Goggins M and Yeo CJ Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 1999, 154:1835-40
9. Goggins M, Hruban RH and Kern SE BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am J Pathol 2000, 156:1767-71
10. Yamamoto H, Itoh F, Nakamura H, Fukushima H, Sasaki S, Perucho M and Imai K Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. Cancer Res 2001, 61:3139-44
11. Nakata B, Wang YQ, Yashiro M, Nishioka N, Tanaka H, Ohira M, Ishikawa T, Nishino H and Hirakawa K Prognostic value of microsatellite instability in resectable pancreatic cancer. Clin Cancer Res 2002, 8:2536-40
12. Wilentz RE, Goggins M, Redston M, Marcus VA, Adsay NV, Sohn TA, Kadkol SS, Yeo CJ, Choti M and Zahurak M Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol 2000, 156:1641-51
13. Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, Kern SE, Klimstra DS, Kloppel G and Longnecker DS Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001, 25:579-86
14. Luttges J, Galehdari H, Brocker V, Schwarte-Waldhoff I, Henne-Bruns D, Kloppel G, Schmiegel W and Hahn SA Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 2001, 158:1677-83
15. Klein WM, Hruban RH, Klein-Szanto AJ and Wilentz RE Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression. Mod Pathol 2002, 15:441-7
16. van Heek NT, Meeker AK, Kern SE, Yeo CJ, Lillemoe KD, Cameron JL, Offerhaus GLA, Hicks JL, Wilentz RE and G MG Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol 2002, 161:1541-1547
17. Fukushima N, Sato N, Ueki T, Rosty C, Walter KM, Wilentz RE, Yeo CJ, Hruban RH and Goggins M Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Am J Pathol 2002, 160:1573-81
18. Sato N, Ueki T, Fukushima N, Iacobuzio-Donahue CA, Yeo CJ, Cameron JL, Hruban RH and Goggins M Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 2002, 123:365-72
19. Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH and Goggins M Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 2000, 60:1835-9
20. Ueki T, Toyota M, Skinner H, Walter KM, Yeo CJ, Issa JP, Hruban RH and Goggins M Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. Cancer Res 2001, 61:8540-6
21. Gress TM, Muller-Pillasch F, Geng M, Zimmerhackl F, Zehetner G, Friess H, Buchler M, Adler G and Lehrach H A pancreatic cancer-specific expression profile. Oncogene 1996, 13:1819-30
22. Michl P, Buchholz M, Rolke M, Kunsch S, Lohr M, McClane B, Tsukita S, Leder G, Adler G and Gress TM Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 2001, 121:678-84
23. Weber CK, Sommer G, Michl P, Fensterer H, Weimer M, Gansauge F, Leder G, Adler G and Gress TM Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology 2001, 121:657-67
24. Wallrapp C, Hahnel S, Muller-Pillasch F, Burghardt B, Iwamura T, Ruthenburger M, Lerch MM, Adler G and Gress TM A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res 2000, 60:2602-6
25. Crnogorac-Jurcevic T, Efthimiou E, Capelli P, Blaveri E, Baron A, Terris B, Jones M, Tyson K, Bassi C and Scarpa A Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 2001, 20:7437-46
26. Friess H, Ding J, Kleeff J, Liao Q, Berberat PO, Hammer J and Buchler MW Identification of disease-specific genes in chronic pancreatitis using DNA array technology. Ann Surg 2001, 234:769-78
27. Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD, Ryu B, Skinner HG, Goggins M and Jaffee EM Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res 2001, 61:4320-4
28. Argani P, Iacobuzio-Donahue C, Ryu B, Rosty C, Goggins M, Wilentz RE, Murugesan SR, Leach SD, Jaffee E and Yeo CJ Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res 2001, 7:3862-8
29. Ryu B, Jones J, Hollingsworth MA, Hruban RH and Kern SE Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res 2001, 61:1833-8
30. Rosty C, Ueki T, Argani P, Jansen M, Yeo CJ, Cameron JL, Hruban RH and Goggins M Overexpression of S100A4 in Pancreatic Ductal Adenocarcinomas Is Associated with Poor Differentiation and DNA Hypomethylation. Am J Pathol 2002, 160:45-50
31. Crnogorac-Jurcevic T, Efthimiou E, Nielsen T, Loader J, Terris B, Stamp G, Baron A, Scarpa A and Lemoine NR Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 2002, 21:4587-94
32. Murphy KM, Brune KA, Griffin C, Sollenberger JE, Petersen GM, Bansal R, Hruban RH and Kern SE Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res 2002, 62:3789-93
33. Moore PS, Zamboni G, Falconi M, Bassi C and Scarpa A A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma. Hum Mutat 2000, 16:447-8
34. Goggins M, Kern SE, Offerhaus JA and Hruban RH Progress in cancer genetics: lessons from pancreatic cancer. Ann Oncol 1999, 10:4-8
35. Pellegata N, Sessa F, Renault B, Bonato M, Leone B, Solcia E and Ranzani G K-ras and p53 mutations in pancreatic cancer: ductal and non-ductal tumors progress through different genetic lesions. Cancer Res 1994, 54:1556-1560
36. Rigaud G, Moore P, Zamboni G, Taruscio D, Paradisi S, Falconi M, Klöppel G and Scarpa A Allelotype of pancreatic acinar cell carcinoma. Int J Cancer 2000, 88:772-777
37. Abraham SC, Wu TT, Hruban RH, Lee JH, Yeo CJ, Conlon K, Brennan M, Cameron JL and Klimstra DS Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol 2002, 160:953-62
38. Moore P, Zamboni G, Brighenti A, Lissandrini D, Antonello D, Capelli P, Rigaud G, Falconi M and Scarpa A Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q. Am J Pathol 2001, 158:317-321
39. Zamboni G, Scarpa A, Bogina G, Iacono C, Bassi C, Talamini G, Sessa F, Capella C, Solcia E and Rickaert F Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 1999, 23:410-22
40. Iacobuzio-Donahue CA, Wilentz RE, Argani P, Yeo CJ, Cameron JL, Kern SE and Hruban RH Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression. Am J Surg Pathol 2000, 24:1544-8
41. Sessa F, Solcia E, Capella C, Bonato M, Scarpa A, Zamboni G, Pellegata N, Ranzani G, Rickaert F and Klöppel G Intraductal papillary-mucinous pancreatic tumors are phenotypically, genetically and behaviorally distinct growths. An analysis of tumor cell phenotype, K-ras and p53 genes' mutations. Virchows Archiv 1994, 425:357-367
42. Terris B, Blaveri E, Crnogorac-Jurcevic T, Jones M, Missiaglia E, Ruszniewski P, Sauvanet A and Lemoine NR Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am J Pathol 2002, 160:1745-54
43. Tanaka Y, Kato K, Notohara K, Hojo H, Ijiri R, Miyake T, Nagahara N, Sasaki F, Kitagawa N and Nakatani Y Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res 2001, 61:8401-4
44. Abraham SC, Klimstra DS, Wilentz RE, Yeo CJ, Conlon K, Brennan M, Cameron JL, Wu TT and Hruban RH Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol 2002, 160:1361-9
45. Scarpa A, Capelli P, Zamboni G, Oda T, Mukai K, Bonetti F, Martignoni G, Iacono C, Serio G and Hirohashi S Neoplasia of the ampulla of Vater: Ki-ras and p53 mutations. Am J Pathol 1993, 142:1163-1172
46. Scarpa A, Zamboni G, Achille A, Capelli P, Bogina G, Iacono C, Serio G and Accolla R Ras-family gene mutations in neoplasia of the ampulla of Vater. Int J Cancer 1994, 59:39-42
47. Howe JR, Klimstra DS, Cordon-Cardo C, Paty PB, Park PY and Brennan MF K-ras mutation in adenomas and carcinomas of the ampulla of vater. Clin Cancer Res 1997, 3:129-33
48. Beghelli S, Orlandini S, Moore PS, Talamini G, Capelli P, Zamboni G, Falconi M and Scarpa A Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis. Virchows Arch 2002, 441:19-24
49. Scarpa A, Di Pace C, Talamini G, Falconi M, Lemoine N, Iacono C, Achille A, Baron A and Zamboni G Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis. Gut 2000, 46:842-848
50. Achille A, Scupoli M, Magalini A, Zamboni G, Romanelli M, Orlandini S, Biasi M, Lemoine N, Accolla R and Scarpa A APC gene mutations and allelic losses in sporadic ampullary tumours: evidence of genetic difference from tumours associated with familial adenomatous polyposis. Int J Cancer 1996, 68:305-312
51. Achille A, Biasi MO, Zamboni G, Bogina G, Iacono C, Talamini G, Capella G and Scarpa A Cancers of the papilla of Vater: mutator phenotype is associated with good prognosis. Clin Cancer Res 1997, 3:1841-1847
52. Gumbs AA, Moore PS, Falconi M, Bassi C, Beghelli S, Modlin I and Scarpa A Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. J Surg Oncol 2002, 81:45-53
53. Beghelli S, Pelosi G, Zamboni G, Falconi M, Iacono C, Bordi C and Scarpa A Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p. J Pathol 1998, 186:41-50
54. Scarpa A, Orlandini S, Moore P, Lemoine N, Beghelli S, Baron A, Falconi M and Zamboni G Dpc-4 is expressed in virtually all primary and metastatic pancreatic endocrine tumors. Virchows Arch 2002, 440:155-159
55. Moore PS, Missiaglia E, Antonello D, Zamo A, Zamboni G, Corleto V, Falconi M and Scarpa A Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. Genes Chromosomes Cancer 2001, 32:177-81
56. Chung DC, Smith AP, Louis DN, Graeme-Cook F, Warshaw AL and Arnold A A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. J Clin Invest 1997, 100:404-10
57. Rigaud G, Missiaglia E, Moore PS, Zamboni G, Falconi M, Talamini G, Pesci A, Baron A, Lissandrini D and Rindi G High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res 2001, 61:285-92
58. Hahn SA, Seymour AB, Hoque AT, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A and Yeo CJ Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 1995, 55:4670-5
59. Rigaud G, Moore PS, Zamboni G, Orlandini S, Taruscio D, Paradisi S, Lemoine NR, Kloppel G and Scarpa A Allelotype of pancreatic acinar cell carcinoma. Int J Cancer 2000, 88:772-7
60. Moore PS, Zamboni G, Brighenti A, Lissandrini D, Antonello D, Capelli P, Rigaud G, Falconi M and Scarpa A Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q. Am J Pathol 2001, 158:317-21
61. Chung DC, Brown SB, Graeme-Cook F, Tillotson LG, Warshaw AL, Jensen RT and Arnold A Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors. Cancer Res 1998, 58:3706-11
62. Missiaglia E, Moore PS, Williamson J, Lemoine NR, Falconi M, Zamboni G and Scarpa A Sex chromosome anomalies in pancreatic endocrine tumors. Int J Cancer 2002, 98:532-8